Roivant President and Immunovant CEO Eric Venker disposes of 200,000 common shares worth $7,324,000
ROIV•Eric Venker sold 200,000 common shares at a weighted-average price of $36.62 on Sept. 30, 2026, reducing his direct stake to 1,599,154 shares. He also exercised options for 200,000 shares at $3.85.
1. Share sale and options
Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares at a weighted-average price of $36.62. The transaction reduced his direct stake to 1,599,154 common shares. Venker also exercised stock options for 200,000 shares at $3.85. The transaction date was Sept. 30, 2026.
